Patients with anterior wall AMI treated by PCI will undergo, after successful revascularization of the infarct artery, measurement of the left ventricular pressure, and femoral angiogram. Patients with elevated LV pressure and adequate femoral access will be randomized to standard pharmacological treatment of AMI vs. mechanical unloading by Impella-CP (on top of the standard treatment) for 36-48 hours. LV unloading will be guided by measurement of PCWP by Swan-Ganz catheter. On the day 4-7, and at 3 months after the AMI, the patients will undergo SPECT and 3D-echocardiography to assess ventricular remodeling and extent of the post-infarct scar. The patients will be followed for at least 12 months for the occurrence of heart failure and adverse cardiovascular events. The study will test the hypothesis, whether the LV mechanical unloading after PCI will attenuate post-infarct scar and cardiac remodeling.
1. Eligible patients with be screened before PCI 2. The patients with undergo coronary angiography and PCI according to common medical practice 3. At the end of the PCI procedure, after a successful revascularization, a pigtail catheter will be used to measure LV filling pressure and to perform femoral angiography (to evaluate femoral access). 4. Patients fulfilling angiographic and hemodynamic criteria will be randomized 1:1 to standard care vs. mechanical unloading by Impella-CP. 5. The patients will be treated on a CCU with experience with use of Impella-CP. 6. On the CCU, all patients will be monitored by a Swan-Ganz catheter for 48 hours. 7. The pump speed will be adjusted to maintain the lowest tolerated PCWP while avoiding suction events. 8. Mechanical unloading will last 36-48h. Afterwards, the Impella-CP will be explanted. 9. All patients will receive standard pharmacotherapy of AMI, according to the guidelines. 10. Revascularization of significant non-infarct lesions will be performed during the index hospitalization. 11. 3D-echocardiography and Tc-SPECT (D-SPECT) will be performed on the day 5-7 of the index hospitalization. LV phasic volumes and extent of nonperfused myocardium (scar) will be evaluated automatically, using software provided by the vendor. 12. 3D-echocardiography and Tc-SPECT will be repeated at 3 months after the AMI. 13. The patients will be followed by out-patient check-ups every 12 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
80
The patients will receive Impella-CP for 36-48 hours. The pump speed and LV unloading will be guided by PCWP (Swan-Ganz catheter)
Institute for Clinical and Experimental Medicine (IKEM)
Prague, Czechia
RECRUITINGDifference in the left ventricular end-systolic volume
Absolute change in the LVESV measured by SPECT and compared between the groups
Time frame: LV end-systolic volume measured during the index hospitalization (day 5-7) and at 3 months
Occurrence of LV remodeling
Occurrence of LV remodeling defined by the increase of LV end-systolic volume \>20%
Time frame: LV end-systolic volume measured during the index hospitalization (day 5-7) and at 3 months
Extent of post-infarct scar
Extent of post-infarct scar measured by Tc-SPECT and compared between the groups
Time frame: LV scar extent measured during the index hospitalization (day 5-7) and at 3 months
CV complications
occurence of TIMI bleeding, hemolysis, thromboembolic events
Time frame: during the first 5 day after AMI
heart failure
acute heart failure requiring inotropes or progression of cardiogenic shock
Time frame: during the first 5 day after AMI
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.